Journal of Pharmaceutical Research

The PDF file you selected should load here if your Web browser has a PDF reader plug-in installed (for example, a recent version of Adobe Acrobat Reader).

If you would like more information about how to print, save, and work with PDFs, Highwire Press provides a helpful Frequently Asked Questions about PDFs.

Alternatively, you can download the PDF file directly to your computer, from where it can be opened using a PDF reader. To download the PDF, click the Download link above.

Fullscreen Fullscreen Off


An accurate, sensitive, rapid and precise HPTLC method for analysis of Nebivolol Hydrochloride and Valsartan in the combination has been developed and validated. Literature survey reveals few stability indicating methods for Nebivolol Hydrochloride and Valsartan as single drugs. There is no stability indicating method reported for these two drugs in combination. By use of HPTLC technique, an optimum separation was achieved on plates precoated with silica gel 60 F254 with mobile phase consisting of Ethyl Acetate:Methanol:Acetic acid. Detection and quantization was performed at 280nm and 240nm for Nebivolol Hydrochloride and Valsartan respectively. Method was validated according to the ICH guidelines. The validation parameters checked were specificity, linearity, accuracy, precision, LOD, LOQ. The drugs were subjected to stress conditions like hydrolysis under acidic, basic and neutral conditions, oxidation, heat and photolysis. The degradation products resulting from stress conditions did not interfere with the detection of drug peak. This method can be used for stability monitoring of these drugs.

Keywords

Valsartan, Nebivolol Hydrochloride, HPTLC, Stability Indicating Method.
User
Notifications
Font Size